Access a multiple offering which is unique in the world

You want access to a multiple offer which is unique in the world and based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe?

A unique ecosystem

Inserm Transfert ensures the promotion and value creation for inventions, materials, know-how and expertise from its laboratories and the related clinical skills. Inserm Transfert sets up a variety of solutions to meet the ever more demanding requirements of companies, either through conventional license agreements and collaboration agreements, or tailored alliances involving several laboratories and expertises. Everything is done to respond as closely as possible to companies’ requirements.

+ 1,600 000

people participating in inserm cohorts

1st

Applicant in Europe for patents in the pharmaceutical sector (EPO ranking 2025)

37

Clinical Investigation Centers

1st

Academic and clinical research institute with more than 13,147 Inserm-affiliated original articles (2024)

1st

Academic and clinical research institute dedicated to human health in Europe

2 Nobel prizes

3 Lasker prizes

1 Japan prize

+ 9 200

Researchers and clinicians

1st

European leader in the health cluster of the Horizon Europe Framework Program (2024)

+ 300

Research units

250 à 300

News invention disclosures per year

3rd

Applicant in Europe for patents in the Biotechnology sector (EPO ranking 2025)

A wealth of richness located throughout France

Inserm Transfert offers access to a rich assets ranging from the expertise of KOL, scientists and clinicians, to innovations obtained from basic translational and clinical research (new targets, signaling pathways etc.), know-how, research, technological & infrastructure platforms, databases, patients or subject cohorts, biobanks, technological research accelerators for ultrasound, bio printing and organ reconstruction, Inserm, multidisciplinary research programs on the microbiota, ageing and genetic variability in cohorts.

See our strategic innovation domains
Visit Inserm's website